Elza Tiemi Sakamoto‐Hojo
Papers
2
Total Citations
25
H-Index
2
About
Elza Tiemi Sakamoto-Hojo is a Brazilian researcher whose work sits at the compelling intersection of genomics, immunogenetics, and metabolic disease. Her research has made meaningful contributions to understanding the molecular underpinnings of Type 1 Diabetes Mellitus (T1D), with a particular focus on gene expression profiling in immune cells and susceptibility regions across the human genome. Among her most recognized contributions is a 2008 study examining gene expression profiles stratified by T1D susceptibility regions, including the major histocompatibility complex (MHC) at chromosome 6p21 and additional loci such as PTPN22, CTLA-4, and the insulin gene — work that has garnered 16 citations. Her earlier 2006 investigation into differential gene expression in lymphomononuclear cells of newly diagnosed T1D patients — employing cDNA microarray technology across thousands of genes — offered early insight into metabolic gene dysregulation at disease onset, accumulating 9 citations. Together, these studies reflect Sakamoto-Hojo's commitment to large-scale transcriptomic approaches as tools for uncovering disease mechanisms. Her research provides valuable foundational knowledge for students and scientists working in autoimmunity, diabetes genetics, and translational genomics.
Research Focus
Key Achievements
Top Papers
- 1
- 2